Jan Wouter Drijfhout

This inventor holds 25 USPTO granted patents and 2 published patent applications, plus 11 CIPO patents and 9 EPO patents, primarily in Bioactive Peptides. Top assignees: Academisch Ziekenhuis Leiden (h.o.d.n. Lumc), Stichting Voor De Technische Wetenschappen, Ludwig Institute for Cancer Research Limited. Active years: 2001-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jan Wouter Drijfhout. Retrieved from https://idiyas.com/inventor/jan-wouter-drijfhout

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 25 (Patent Applications = 2)

% Patents Active = 48.0

CIPO Patents = 11 (Patent Applications = 7)

EPO Patents = 9 (Patent Applications = 10)

Average Co-Inventor Count = 4.6

ph-index = 4

Forward Citations = 59(Granted Patents)

Company Filing History:

9 out of 43

Academisch Ziekenhuis Leiden (h.o.d.n. Lumc)

patents

6 out of 82

Stichting Voor De Technische Wetenschappen

patents

5 out of 530

Ludwig Institute for Cancer Research Limited

patents

4. 3 out of 47

Academisch Ziekenhuis Leiden

Inova Diagnostics, Inc.

Leiden University Medical Center

patents

9. 2 out of 621

Memorial Sloan Kettering Cancer Center

patents

10. 1 out of 28

Academisch Medisch Centrum

Octoplus Technologies B.v.

patent

14. 1 out of 834,570

Other

patents

where one patent can have more than one assignee

Years Active: 2001-2024

Loading Chart...

Areas of Expertise:

Bioactive Peptides

Rheumatoid Arthritis

Immunogenic Compositions

Antimicrobial Peptides

Peptide Inhibitors

Cell Lysis

Nucleic Acid Molecules

Assay Kits

Peptide Conjugates

Auto-Antibodies

NY-ESO-1 Protein

MHC Class II

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12037372 - Bioactive peptides derived from snakes (2024-07-16),

2. 11680088 - Bioactive peptides derived from snakes (2023-06-20),

3. 10684284 - Compositions and methods for the diagnosis of rheumatoid arthritis (2020-06-16),

4. 10450356 - PRAME derived peptides and immunogenic compositions comprising these (2019-10-22),

5. 10130677 - Antimicrobial peptide and uses thereof (2018-11-20),

6. 10119966 - Method of detecting auto-antibodies from patients suffering from rheumatoid arthritis, a peptide and assay kit (2018-11-06),

7. 9829489 - Compositions and methods for the diagnosis of rheumatoid arthritis (2017-11-28),

8. 9689871 - Method of detecting auto-antibodies from patients suffering from rheumatoid arthritis, a peptide and an assay kit (2017-06-27),

9. 9562085 - Antimicrobial peptide (2017-02-07),

10. 9522962 - Peptides, conjugates and method for increasing immunogenicity of a vaccine (2016-12-20),

11. 9441025 - Prame derived peptides and immunogenic compositions comprising these (2016-09-13),

12. 8759114 - Method of detecting auto-antibodies from patients suffering from rheumatoid arthritis, a peptide and an assay kit (2014-06-24),

13. 8541202 - Method for inducing cell lysis with immunogenic portions of NY-ESO-1 protein (2013-09-24),

14. 8492514 - PRAME derived peptides and immunogenic compositions comprising these (2013-07-23),

15. 8481332 - Method of detecting auto-antibodies from patients suffering from rheumatoid arthritis, a peptide and an assay kit (2013-07-09),

Title: Jan Wouter Drijfhout: Innovator in Bioactive Peptides

Introduction

Jan Wouter Drijfhout, based in Leiden, Netherlands, is a notable inventor with an impressive portfolio of 25 patents. His innovative work centers around bioactive peptides derived from snakes, which hold significant potential for medicinal applications.

Latest Patents

Among his latest innovations, Drijfhout has disclosed bioactive peptides derived from snakes. These peptides are specifically designed to inhibit bacterial, fungal, viral, and parasitic infections. Additionally, they offer promising applications in the treatment of inflammatory conditions and cancers. The dual utility of these peptides marks a significant advancement in the field of biomedical research.

Career Highlights

Drijfhout has had a productive career, contributing his expertise at reputable institutions such as Academisch Ziekenhuis Leiden, commonly known as LUMC, and the Ludwig Institute for Cancer Research Limited. These affiliations have allowed him to collaborate on groundbreaking research and develop his patented inventions further.

Collaborations

Throughout his career, Drijfhout has worked closely with esteemed colleagues, including Yao-tseng Chen and Matthew J. Scanlan. Their collaborative efforts have undoubtedly played a role in the successful development of his innovative ideas and patents.

Conclusion

Jan Wouter Drijfhout's contributions to the field of bioactive peptides represent a valuable addition to medical science. His extensive patent portfolio highlights his commitment to innovation and the meaningful impact his work may have on treating various health conditions. As his research continues to evolve, Drijfhout remains a prominent figure in the exploration of snake-derived peptides for therapeutic purposes.

Profile summary based on public USPTO records.